Case Study: Making the most of NICE
The task
- Explore the risk management considerations of the NICE guidance on anti-TNF therapy in rheumatoid arthritis to identify benefits of our client's product
Our solution
- Create a virtual debate between rheumatologists, rheumatology nurses, medico-legal experts and patients to establish the risk management benefits of hospital-administered therapies
- Develop a speaker slide kit and best practice patient toolbox to support our client's brand
The result
- The virtual debate reinforced the positioning of our client's anti-TNF drug as the safest in its class – a favoured hospital administered therapy
Going beyond
- The risk management message of IV-administered therapy successfully stalled the competitor message
